Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML. (Q35022505)
scientific article
Language:
(P31) (Q13442814)
(Q7318358)
(P50) (Q373427)
(P304) 8541-8546
(P407) (Q1860)
(P433) 56
(P478) 21
(P577) Sunday, December 1, 2002
(P1433) (Q1568657)
(P1476) "Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML." (language: en)
(P2860) (Q40590227)
(Q43966244)
(Q35655027)
(Q34134516)
(Q29618610)
(Q24599829)
(Q33336718)
(Q29547900)
(Q28277030)
(Q41056381)
(Q29618788)
(Q43833442)
(Q43893091)
(Q43977712)
(Q41716788)
(Q44072012)
(Q43899710)
(Q40716128)
(Q41740883)
(Q43847745)
(Q40814460)
(Q33343973)
(Q43614308)
(Q44071998)
(Q43977683)
(Q27627097)
(Q30176087)
(Q29615030)
(Q33491174)
(Q43551005)
(Q43904522)
(Q28512170)
(Q45712588)
(Q34171417)
(Q34366423)
(Q37115205)
(Q41668856)
(Q73030493)
(Q77922880)
(Q73795156)
(Q44042018)
(Q70220517)
other details
description scientific article

External Links